The Americans with Disabilities Act, landmark legislation enshrining civil rights for people with disabilities, was signed on ...

American Diabetes Association (ADA) 85th Scientific Sessions Restoration of Normoglycemia via Subcutaneous Transplantation of Islets in FRESH 3D Printed ECM-Based Scaffolds ...

American Diabetes Association (ADA) 85th Scientific Sessions Restoration of Normoglycemia via Subcutaneous Transplantation of Islets in FRESH 3D Printed ECM-Based Scaffolds ...

The biotechnology company attended the American Diabetes Association meeting and presented new results from its UP421 cadaveric pancreatic islet cell program. The findings showed that people with ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.

All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

Greater weight loss and more diabetes remission seen among adult women with overweight, obesity and T2D. (HealthDay News) — For adult women with overweight or obesity and type 2 diabetes (T2D ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early ...

iRhythm Technologies reports high prevalence of cardiac arrhythmias in type 2 diabetes patients associated with chronic kidney disease, highlighting early detection importance.

Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials.

“Our preclinical data demonstrated that APJ activation can confer multiple benefits in models of diabetic obesity and heart failure, and enhance the effects of incretin therapy,” said Kristen ...